IE00B91XRN20
IE00B91XRN20
Prothena Corporation plc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 453.82M EUR | 506.58M EUR | 515.91M EUR | 514.1M EUR |
Enterprise Value | 160.81M EUR | 225.37M EUR | 194.1M EUR | 214.95M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -5.82x | -- | -- | -- |
Price to Sales | 8.32x | 9.29x | 8.9x | 74.99x |
Price to Book | 1.59x | 1.77x | 1.65x | 1.83x |
EV/Revenue | 2.95x | 4.13x | 3.35x | 31.35x |
EV/EBITDA | -2.72x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -11.95% | -11.98% | -15.78% | -21.46% |